TradeTrade
Jump to any asset 850 assets, updated daily

As of September 12, 2026, Injective (INJ) trades at $5.94. CleaRank's model target is $5.62, derived from technical levels rather than analyst coverage. RSI at 62 is in neutral territory, and the price is above its 50-day average of $4.97.

Injective (INJ/USD)

Injective

$5.94 -0.2300 (-3.73%)
Latest Price
AI Analyst Consensus
Buy
75 / 100

Injective (INJ) Price Action and Adoption

Injective (INJ) is currently trading at $5.94, demonstrating a positive trend as its price is above the 50-day SMA ($4.97), 200-day SMA ($4.38), and 20-day EMA ($5.45). This positioning suggests that the moving averages are acting as support for the asset. The RSI is at 62.06, indicating bullish momentum without being overbought, aligning with the asset's upward price trajectory.

The network's activity and adoption are key drivers for Injective. With a market capitalization of $594,025,087, INJ shows significant investor interest. Continued development and integration within the DeFi ecosystem are expected to further strengthen its network value and utility, supporting the current bullish technicals.

INJ/USD Price Analysis

Market Position Analysis

Market Dominance

#97
Top 100
By Market Capitalization

Key Metrics Overview

Market Cap
594.03M
24h Volume
$96.15M
24h Change
-3.73%
From ATH
-88.7%
Market Intelligence
Injective ranks #97 by market capitalization. Consider liquidity and market depth when evaluating position sizes.

Price History & Milestones

All-Time High
$52.62
Mar 14, 2024
All-Time Low
$0.6574
Nov 3, 2020

Current Price Position

ATL: $0.6574 Current: $5.94 ATH: $52.62
πŸ“‰ Lower Range - Consolidating below historical midpoint
24-Hour Trading Activity
Low: $5.70
High: $6.12
Volume: $96.15M

INJ/USD Analysis

CleaRank AI Target -5.39% Downside
Our model estimate (not an analyst consensus)
$5.620
AI Technical Analysis Buy

Injective (INJ) Technical Indicators

Injective (INJ) is currently trading above its key moving averages, with the price at $5.94 surpassing the 50-day SMA of $4.97, the 200-day SMA of $4.38, and the 20-day EMA of $5.45. This indicates that these averages are currently acting as support levels. The RSI is at 62.06, which is categorized as bullish, suggesting strong upward momentum. The Commodity Channel Index (CCI) is at 57.12, further supporting the bullish sentiment by indicating that the price is above its historical average.

The MACD is at 0.29, showing positive momentum. The stochastic indicator is at 62.33, also in bullish territory. Overall, the technical indicators for Injective point towards a strong bullish outlook, with multiple indicators confirming upward price pressure and the potential for continued gains, provided these support levels hold.

ProTips
  • Monitor Injective's 20-day EMA ($5.45) as a key short-term support level.
  • Keep an eye on broader cryptocurrency market trends, as they significantly influence INJ's price action.
  • Track Injective's ecosystem development and new partnerships for potential catalysts.
Market Outlook

Injective (INJ) 6-12 Month Forecast

The outlook for Injective (INJ) over the next 6 to 12 months is cautiously optimistic, driven by its current bullish technicals and ongoing ecosystem development. The price is trading above key support levels, and the RSI indicates strong momentum. Continued adoption of its DeFi protocols and potential new integrations could see INJ test higher price levels.

Key resistance levels will be important to watch, alongside broader market sentiment. If Injective can maintain its development pace and attract further user activity, it could see significant appreciation. Conversely, a downturn in the broader crypto market or increased regulatory pressure could challenge this positive outlook, potentially leading to price consolidation or a pullback towards its support zones.

Market Correlations

How this crypto moves relative to other assets

Based on 1 year of daily price data. Correlations may vary over different time periods.

S&P 500 (SPY) +0.33
Weak correlation
Nasdaq 100 (QQQ) +0.26
Weak correlation
Bitcoin (BTC) +0.49
Moderate correlation
Gold (XAU) +0.05
Weak correlation
Check Custom Correlation

Valuation Metrics

Market Cap 594.03M
Market Cap Rank #97
Circulating Supply 100.00M
Max Supply ∞ Unlimited
All-Time High $52.62
All-Time Low $0.6574
Injective has a market capitalization of $594.03M. This asset has no supply cap, meaning new tokens can be created indefinitely. At 88.7% below its all-time high of $52.62, the asset is in a deep drawdown.

Earnings & Growth Analysis

Injective (INJ) Ecosystem Growth Metrics

Injective's growth is primarily measured by its network expansion and the increasing adoption of its DeFi protocols. Metrics such as the number of active developers, new smart contract deployments, and total value locked (TVL) within its ecosystem are critical indicators of its health. The platform's ability to attract and retain users through innovative features and competitive transaction fees drives its on-chain activity.

The ongoing development and successful integration of new applications on the Injective chain contribute to its overall ecosystem expansion. Monitoring these on-chain metrics provides insight into the organic growth and utility of the Injective network, which are fundamental to its long-term success.

Key Risks

Injective (INJ) Key Risks

A primary risk for Injective (INJ) is the inherent volatility within the cryptocurrency market, which can lead to rapid price swings. Regulatory uncertainty surrounding digital assets globally also poses a significant risk, potentially impacting adoption and market access. Also, competition within the DeFi sector is intense, and Injective must continuously innovate to maintain its market position and attract users.

Technical Indicators i

RSI (14) 62.06
MACD 0.29
SMA 50 4.97
SMA 200 4.38
Technical Rating Bullish
RSI
Bullish
SMA Cross
Bullish
Price vs SMA
Bullish
MACD
Bullish
Golden Cross in effect with the 50-day SMA ($4.972) above the 200-day SMA ($4.378), price action is firmly bullish above key moving averages.

INJ/USD Trade Plans

Specific entry, exit, and risk management levels

Select Your Trade Bias
Risk Tolerance
Conservative 2% Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →

🟒 LONG ENTRY (click to switch)

CONSERVATIVE
$5.821
2% below current price (Pullback entry)
Lower risk, wait for pullback
AGGRESSIVE
$5.940
Buy at current price
Higher risk, immediate entry

Risk Management

STOP LOSS
$4.983
MAX LOSS
-14.4%
Volatility-Adjusted Stop Loss
Calculated based on RSI (62.1) and current market volatility

Profit Targets (Based on Conservative Entry)

TARGET 1
$6.112
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$6.403
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$6.694
+15% (Conservative)
+12.7% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
⚠️ Cryptocurrency Risk Disclaimer
This AI-generated analysis of INJ/USD is for educational purposes only. Cryptocurrency is highly speculative, volatile, and largely unregulated. Risks include exchange hacks, smart contract vulnerabilities, de-pegging events, regulatory bans, and total loss of investment. CleaRank does not custody or facilitate cryptocurrency trades. This is not financial advice. Generated on September 12, 2026.

Growth of $10,000

A $10,000 investment in INJ/USD in September 2025 would be worth about $4,109 today, compared with about $11,626 for the same investment in the S&P 500 benchmark.

Compare with Another Ticker

Monte Carlo Projection (10yr)

CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in INJ/USD today could grow to about $8,709 by 2036 in the base case, with a bull case near $66,069 and a bear case around $1,148. Projections are statistical simulations, not guarantees.

INJ/USD Price Prediction: 2030

CleaRank's simulation projects a price near $5.62 for INJ/USD by 2030 in the base case, from $5.94 today (0.9x over 4 years). The downside path ends near $1.56. These are outcomes of a Monte Carlo simulation run on INJ/USD's historical return distribution, not price targets, and they assume no dividends are reinvested.

INJ/USD simulated price paths by year
Year Downside (10th pct) Base case Upside (90th pct)
2027 $3.09 $5.86 $11.12
2028 $2.33 $5.78 $14.30
2029 $1.88 $5.70 $17.29
2030 $1.56 $5.62 $20.25
2031 $1.32 $5.54 $23.23
2032 $1.14 $5.47 $26.27
2033 $0.9896 $5.39 $29.38
2034 $0.8682 $5.32 $32.57
2035 $0.7671 $5.24 $35.86
2036 $0.6818 $5.17 $39.24

Method: 10,000 simulated price paths using INJ/USD's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.

People Also Watch

On-Chain & Market Metrics

24h Volume
$96.15M
24h Range
$5.70 to $6.12
From ATH
-88.71%
ATH: $52.62
Market Rank
#97
By Market Cap

Supply Economics

Circulating Supply 100.00M
∞ Unlimited Supply - This asset has no max supply cap

Frequently Asked Questions

What is the injective price prediction for 2030?
According to Monte Carlo simulations, the base case price prediction for Injective (INJ) in 2030 is $5.62. The downside scenario suggests a price of $1.56, while the upside scenario projects $20.25. These figures are statistical outcomes and not guarantees.
Is Injective (INJ) a buy right now?
Injective (INJ) is showing strong bullish momentum with its price trading above key moving averages (50-day SMA, 200-day SMA, 20-day EMA) and a bullish RSI status of 62.06. This suggests it could be a favorable time to consider buying, provided support levels hold.
What are the main technical indicators for Injective (INJ)?
Key technical indicators for Injective (INJ) include a bullish RSI at 62.1, a positive MACD of 0.29, and a stochastic indicator at 62.33. The price is also trading above its 50-day SMA ($4.97), 200-day SMA ($4.38), and 20-day EMA ($5.45), indicating strong upward momentum.
How is Injective's network activity trending?
Injective's network activity is driven by its growing DeFi ecosystem and developer adoption. While specific on-chain metrics like transaction volume and active addresses are not detailed here, the platform's increasing market capitalization suggests positive underlying network growth.
What are the biggest risks facing Injective (INJ)?
The primary risks for Injective (INJ) include general cryptocurrency market volatility, potential regulatory changes affecting digital assets, and intense competition within the decentralized finance sector.
What is the long-term outlook for Injective (INJ)?
The long-term outlook for Injective (INJ) appears positive, supported by its strong technicals and growing adoption in the DeFi space. Continued innovation and ecosystem expansion are expected to drive future value.
Does Injective (INJ) have strong community support?
While specific community metrics are not provided, Injective's active development and presence in the DeFi space suggest a dedicated community of users and developers contributing to its ecosystem's growth.

Disclaimer: CleaRank.com is a financial data and analytics provider, not a registered investment advisor, broker-dealer, or financial regulatory body. The cryptocurrency analysis, trade plans, and AI-generated signals presented for INJ/USD are for educational and informational purposes only and do not constitute financial advice or an offer to buy or sell any digital assets. Cryptocurrency markets are highly volatile, largely unregulated, and subject to unique risks including but not limited to: exchange hacks, smart contract vulnerabilities, regulatory bans, de-pegging events, and total loss of investment. Digital asset prices can fluctuate dramatically within hours. CleaRank does not custody, broker, or facilitate trades in any cryptocurrency. All analysis is AI-generated based on historical price data and technical indicators, which may not reflect future performance. Market data is provided "as-is" and may be delayed. You should never invest money you cannot afford to lose. Consult a qualified financial advisor before making any investment decisions. Analysis generated on September 12, 2026.